JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB239924

Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free

  • BOND RX™ Validated
  • RabMAb
  • Recombinant
  • KO Validated
  • What is this?

4

(2 Reviews)

|

(11 Publications)

Rabbit Recombinant Monoclonal ACE2 antibody. Carrier free. Suitable for IHC-P, IP, WB, I-ELISA and reacts with Mouse, Rat, Human, Synthetic peptide - Human samples. Cited in 11 publications.

View Alternative Names

UNQ868/PRO1885, ACE2, Angiotensin-converting enzyme 2, Angiotensin-converting enzyme homolog, Angiotensin-converting enzyme-related carboxypeptidase, Metalloprotease MPROT15, ACEH, ACE-related carboxypeptidase

12 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (AB239924)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (AB239924)

This data was developed using ab108252 the same antibody clone in a different buffer formulation.

Immunohistochemical analysis of formalin fixed paraffin embedded human kidney labelling ACE2 with ab108252 at a concentration of 0.01µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32 mins. ab108252 Anti-ACE2 antibody [EPR4435(2)] was incubated for 16 mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.

Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (AB239924)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (AB239924)

This data was developed using ab108252 the same antibody clone in a different buffer formulation.

Immunohistochemical analysis of formalin fixed paraffin embedded human testis labelling ACE2 with ab108252 at a concentration of 0.01µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32 mins. ab108252 Anti-ACE2 antibody [EPR4435(2)] was incubated for 16 mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.

Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (AB239924)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (AB239924)

This data was developed using ab108252, the same antibody clone in a different buffer formulation.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human kidney tissue labeling ACE2 with ab108252 at 1/6400 dilution. Heat mediated antigen retrieval was performed using Bond™ Epitope Retrieval Solution 2 (pH 9.0) for 20 minutes. Staining was visualised using Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Negative control using PBS instead of primary antibody. Counterstained with hematoxylin.

The section was incubated with ab108252 for 30 mins at room temperature.

The immunostaining was performed on a Leica Biosystems BOND® RX instrument.

Immunoprecipitation - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (AB239924)
  • IP

Lab

Immunoprecipitation - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (AB239924)

ab239924 Immunoprecipitating ACE2 in human testis tissue lysate. 0.35 mg of tissue lysate was incubated with 2 μg primary antibody (1/50). For western blotting a HRP-conjugated Veriblot for IP Detection Reagent (ab131366) (1/1000) was used to confirm successful immunoprecipitation.

Exposure time : 1 second.
Blocking buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM /TBST.

All lanes:

Immunoprecipitation - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (ab239924) at 1/500 dilution

Lane 1:

Human testis tissue lysate at 10 µg

Lane 2:

ab239924 + Human testis tissue lysate

Lane 3:

Rabbit monoclonal IgG (<a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a>) instead of ab239924 in Human testis tissue lysate

Predicted band size: 92 kDa

Observed band size: 110 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (AB239924)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (AB239924)

This data was developed using ab108252, the same antibody clone in a different buffer formulation.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of rat kidney tissue labeling ACE2 with ab108252 at 1/6400 dilution. Heat mediated antigen retrieval was performed using Bond™ Epitope Retrieval Solution 2 (pH 9.0) for 20 minutes. Staining was visualised using Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Negative control using PBS instead of primary antibody. Counterstained with hematoxylin.

The section was incubated with ab108252 for 30 mins at room temperature.

The immunostaining was performed on a Leica Biosystems BOND® RX instrument.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (AB239924)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (AB239924)

This data was developed using ab108252, the same antibody clone in a different buffer formulation.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of mouse kidney tissue labeling ACE2 with ab108252 at 1/6400 dilution. Heat mediated antigen retrieval was performed using Bond™ Epitope Retrieval Solution 2 (pH 9.0) for 20 minutes. Staining was visualised using Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Negative control using PBS instead of primary antibody. Counterstained with hematoxylin.

The section was incubated with ab108252 for 30 mins at room temperature.

The immunostaining was performed on a Leica Biosystems BOND® RX instrument.

Western blot - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (AB239924)
  • WB

Lab

Western blot - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (AB239924)

This data was developed using ab108252, the same antibody clone in a different buffer formulation. Blocking and diluting buffer and concentration : 5% NFDM/TBST. ab181602 was used as a GAPDH loading control. Two bands observed by ab108252 corresponding to glycosylation and non-glycosylation forms. Signal in heart tissue is low, we recommend loading more amount of lysate or using lower antibody dilution to improve result.

All lanes:

Western blot - Anti-ACE2 antibody [EPR4435(2)] (<a href='/en-us/products/primary-antibodies/ace2-antibody-epr44352-ab108252'>ab108252</a>) at 1/1000 dilution

Lane 1:

Human heart tissue lysate at 20 µg

Lane 2:

Rat heart tissue lysate at 20 µg

Secondary

All lanes:

Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution

Predicted band size: 92 kDa

Observed band size: 110 kDa,120 kDa

false

Exposure time: 180s

Western blot - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (AB239924)
  • WB

Lab

Western blot - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (AB239924)

This data was developed using the same antibody clone in a different buffer formulation (ab108252).

Lanes 1 - 4 : Merged signal (red and green). Green - ab108252 observed at 125 kDa. Red - loading control ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37kDa.

ab108252 was shown to react with ACE2 in Caco-2 wild-type cells in western blot with loss of signal observed in ACE2 knockout cell line ab273731 (knockout cell lysate ab275516). Wild-type and ACE2 knockout Caco-2 cell lysates were subjected to SDS-PAGE. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with ab108252 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4°C at a 1 in 1000 Dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-ACE2 antibody [EPR4435(2)] (<a href='/en-us/products/primary-antibodies/ace2-antibody-epr44352-ab108252'>ab108252</a>) at 1/1000 dilution

Lane 1:

Wild-type Caco-2 cell lysate at 30 µg

Lane 2:

ACE2 knockout Caco-2 cell lysate at 30 µg

Lane 2:

Western blot - Human ACE2 knockout Caco-2 cell line (<a href='/en-us/products/cell-lines/human-ace2-knockout-caco-2-cell-line-ab273731'>ab273731</a>)

Lane 3:

Calu-3 cell lysate at 30 µg

Lane 4:

A549 cell lysate at 30 µg

Predicted band size: 104 kDa,60 kDa,76 kDa,92 kDa

Observed band size: 125 kDa,75 kDa

false

Western blot - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (AB239924)
  • WB

Lab

Western blot - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (AB239924)

This data was developed using ab108252, the same antibody clone in a different buffer formulation.

Lanes 1 - 4 : Merged signal (red and green). Green - ab108252 observed at 130 kDa. Red - loading control ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37kDa.

ab108252 was shown to react with ACE2 in wild-type HepG2 cells in western blot with loss of signal observed in ACE2 knockout cell line ab273733 (knockout cell lysate ab275495). Wild-type and ACE2 knockout HepG2 cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab108252 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-ACE2 antibody [EPR4435(2)] (<a href='/en-us/products/primary-antibodies/ace2-antibody-epr44352-ab108252'>ab108252</a>) at 1/1000 dilution

Lane 1:

Wild-type HepG2 cell lysate at 30 µg

Lane 2:

ACE2 knockout HepG2 cell lysate at 30 µg

Lane 3:

Calu-3 cell lysate at 30 µg

Lane 4:

A549 cell lysate at 30 µg

Predicted band size: 92 kDa

Observed band size: 130 kDa

false

Western blot - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (AB239924)
  • WB

Lab

Western blot - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (AB239924)

This data was developed using ab108252, the same antibody clone in a different buffer formulation. Different batches of ab108252 were tested on Human kidney lysate at 0.2 µg/ml. 15 µg of lysate was loaded in each lane. Bands observed at 120 kDa.

All lanes:

Western blot - Anti-ACE2 antibody [EPR4435(2)] (<a href='/en-us/products/primary-antibodies/ace2-antibody-epr44352-ab108252'>ab108252</a>)

Predicted band size: 92 kDa

false

Western blot - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (AB239924)
  • WB

Lab

Western blot - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (AB239924)

This data was developed using ab108252, the same antibody clone in a different buffer formulation. Blocking and diluting buffer and concentration : 5% NFDM/TBST. ab181602 was used as GAPDH loading control. Exposure time : Lane 1 : 7 seconds; Lane 2-8 : 180 seconds. Two bands observed by ab108252 corresponding to glycosylation and non-glycosylation forms. Signal in mouse and rat tissues are low, we recommend loading more amount of lysate or using lower antibody dilution to improve result.

All lanes:

Western blot - Anti-ACE2 antibody [EPR4435(2)] (<a href='/en-us/products/primary-antibodies/ace2-antibody-epr44352-ab108252'>ab108252</a>) at 1/1000 dilution

Lane 1:

Human testis tissue lysate at 20 µg

Lane 2:

Human lung tissue lysate at 20 µg

Lane 3:

Mouse testis tissue lysate

Lane 4:

Mouse spleen tissue lysate

Lane 5:

Mouse lung tissue lysate

Lane 6:

Rat testis tissue lysate

Lane 7:

Rat spleen tissue lysate

Lane 8:

Rat lung tissue lysate

Secondary

All lanes:

Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution

Predicted band size: 92 kDa

Observed band size: 110 kDa,120 kDa

false

Western blot - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (AB239924)
  • WB

Unknown

Western blot - Anti-ACE2 antibody [EPR4435(2)] - BSA and Azide free (AB239924)

All lanes:

Western blot - Anti-ACE2 antibody [EPR4435(2)] (<a href='/en-us/products/primary-antibodies/ace2-antibody-epr44352-ab108252'>ab108252</a>) at 1/1000 dilution

Lane 1:

Human fetal kidney lysate at 10 µg

Lane 2:

Human testis lysate at 10 µg

Predicted band size: 92 kDa

false

  • Unconjugated

    Anti-ACE2 antibody [EPR4435(2)]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-ACE2 antibody [EPR4435(2)]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-Angiotensin Converting Enzyme 2 antibody [EPR4435(2)]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-Angiotensin Converting Enzyme 2 antibody [EPR4435(2)]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-Angiotensin Converting Enzyme 2 antibody [EPR4435(2)]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR4435(2)

Isotype

IgG

Carrier free

Yes

Reacts with

Mouse, Rat, Human

Applications

I-ELISA, IHC-P, IP, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IELISA" : {"fullname" : "Indirect ELISA", "shortname":"I-ELISA"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IELISA-species-checked": "guaranteed", "IELISA-species-dilution-info": "", "IELISA-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IELISA-species-checked": "guaranteed", "IELISA-species-dilution-info": "", "IELISA-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>" }, "Rat": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IELISA-species-checked": "guaranteed", "IELISA-species-dilution-info": "", "IELISA-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>" }, "Synthetic peptide - Human": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "IELISA-species-checked": "testedAndGuaranteed", "IELISA-species-dilution-info": "", "IELISA-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "" } } }

Product details

ab239924 is the carrier-free version of ab108252.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.

Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.

Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Do Not Freeze

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The ACE2 protein also known as angiotensin-converting enzyme 2 is an essential component in the renin-angiotensin system. It functions mechanically by converting the hormone angiotensin II to angiotensin-(1-7) which helps regulate blood pressure and fluid balance. The molecular weight of ACE2 is approximately 120 kDa. This protein is expressed in various tissues particularly the lungs heart kidneys and gastrointestinal tract. In cultured cells like Caco-2 cells researchers often study this expression.
Biological function summary

The ACE2 protein plays an important role in the regulation of cardiovascular and renal functions. It is a single-pass type I membrane protein and its activity reduces inflammation and oxidative stress in cells. ACE2 does not function as part of a larger protein complex but its enzymatic conversion has a substantial impact on reducing the effects of angiotensin II in the body leading to vasodilation and decreased blood pressure.

Pathways

ACE2 involvement is significant in the renin-angiotensin system and the kallikrein-kinin system. These pathways are essential for maintaining cardiovascular homeostasis. In the renin-angiotensin system ACE2 works in opposition to angiotensin-converting enzyme (ACE) balancing the effects through the production of angiotensin-(1-7) from angiotensin II. Additionally ACE2 interacts indirectly with proteins like angiotensin receptor type 1 (AT1) and angiotensin receptor type 2 (AT2) ensuring proper signaling and physiological responses.

ACE2 links closely with conditions such as hypertension and COVID-19. Increased activity of angiotensin II due to low ACE2 levels contributes to hypertension. In infectious disease SARS-CoV-2 virus responsible for COVID-19 uses ACE2 as an entry receptor to initiate infection in host cells. This interaction highlights the importance of ACE2 in disease pathogenesis and has prompted interest in ACE2 as a potential therapeutic target.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Essential counter-regulatory carboxypeptidase of the renin-angiotensin hormone system that is a critical regulator of blood volume, systemic vascular resistance, and thus cardiovascular homeostasis (PubMed : 27217402). Converts angiotensin I to angiotensin 1-9, a nine-amino acid peptide with anti-hypertrophic effects in cardiomyocytes, and angiotensin II to angiotensin 1-7, which then acts as a beneficial vasodilator and anti-proliferation agent, counterbalancing the actions of the vasoconstrictor angiotensin II (PubMed : 10924499, PubMed : 10969042, PubMed : 11815627, PubMed : 14504186, PubMed : 19021774). Also removes the C-terminal residue from three other vasoactive peptides, neurotensin, kinetensin, and des-Arg bradykinin, but is not active on bradykinin (PubMed : 10969042, PubMed : 11815627). Also cleaves other biological peptides, such as apelins (apelin-13, [Pyr1]apelin-13, apelin-17, apelin-36), casomorphins (beta-casomorphin-7, neocasomorphin) and dynorphin A with high efficiency (PubMed : 11815627, PubMed : 27217402, PubMed : 28293165). In addition, ACE2 C-terminus is homologous to collectrin and is responsible for the trafficking of the neutral amino acid transporter SL6A19 to the plasma membrane of gut epithelial cells via direct interaction, regulating its expression on the cell surface and its catalytic activity (PubMed : 18424768, PubMed : 19185582).. (Microbial infection) Acts as a receptor for human coronaviruses SARS-CoV and SARS-CoV-2, as well as human coronavirus NL63/HCoV-NL63.. Isoform 2. Non-functional as a carboxypeptidase.. Isoform 2. (Microbial infection) Non-functional as a receptor for human coronavirus SARS-CoV-2.
See full target information ACE2

Publications (11)

Recent publications for all applications. Explore the full list and refine your search

eLife 13: PubMed39412391

2024

Negative regulation of APC/C activation by MAPK-mediated attenuation of Cdc20 under stress.

Applications

Unspecified application

Species

Unspecified reactive species

Li Sun,Xuejin Chen,Chunlin Song,Wenjing Shi,Libo Liu,Shuang Bai,Xi Wang,Jiali Chen,Chengyu Jiang,Shuang-Min Wang,Zhou-Qing Luo,Ruiwen Wang,Yamei Wang,Quan-Wen Jin

ACS nano 16:12276-12289 PubMed35921522

2022

Genetically Engineered MRI-Trackable Extracellular Vesicles as SARS-CoV-2 Mimetics for Mapping ACE2 Binding .

Applications

Unspecified application

Species

Unspecified reactive species

Andrea Galisova,Jiri Zahradnik,Hyla Allouche-Arnon,Mattia I Morandi,Paula Abou Karam,Michal Fisler,Ori Avinoam,Neta Regev-Rudzki,Gideon Schreiber,Amnon Bar-Shir

Frontiers in cardiovascular medicine 9:842641 PubMed35402570

2022

Drug Screening Approach Using L1000-Based Connectivity Map and Its Application to COVID-19.

Applications

Unspecified application

Species

Unspecified reactive species

Takaharu Asano,Sarvesh Chelvanambi,Julius L Decano,Mary C Whelan,Elena Aikawa,Masanori Aikawa

Nutrients 13: PubMed34684358

2021

Obesogenic and Ketogenic Diets Distinctly Regulate the SARS-CoV-2 Entry Proteins ACE2 and TMPRSS2 and the Renin-Angiotensin System in Rat Lung and Heart Tissues.

Applications

Unspecified application

Species

Unspecified reactive species

Daniel Da Eira,Shailee Jani,Rolando B Ceddia

Journal of virology 95:e0125721 PubMed34523966

2021

The NF-κB Transcriptional Footprint Is Essential for SARS-CoV-2 Replication.

Applications

Unspecified application

Species

Unspecified reactive species

Benjamin E Nilsson-Payant,Skyler Uhl,Adrien Grimont,Ashley S Doane,Phillip Cohen,Roosheel S Patel,Christina A Higgins,Joshua A Acklin,Yaron Bram,Vasuretha Chandar,Daniel Blanco-Melo,Maryline Panis,Jean K Lim,Olivier Elemento,Robert E Schwartz,Brad R Rosenberg,Rohit Chandwani,Benjamin R tenOever

Nature biomedical engineering 5:815-829 PubMed33941899

2021

A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics.

Applications

Unspecified application

Species

Unspecified reactive species

Longlong Si,Haiqing Bai,Melissa Rodas,Wuji Cao,Crystal Yuri Oh,Amanda Jiang,Rasmus Moller,Daisy Hoagland,Kohei Oishi,Shu Horiuchi,Skyler Uhl,Daniel Blanco-Melo,Randy A Albrecht,Wen-Chun Liu,Tristan Jordan,Benjamin E Nilsson-Payant,Ilona Golynker,Justin Frere,James Logue,Robert Haupt,Marisa McGrath,Stuart Weston,Tian Zhang,Roberto Plebani,Mercy Soong,Atiq Nurani,Seong Min Kim,Danni Y Zhu,Kambez H Benam,Girija Goyal,Sarah E Gilpin,Rachelle Prantil-Baun,Steven P Gygi,Rani K Powers,Kenneth E Carlson,Matthew Frieman,Benjamin R tenOever,Donald E Ingber

EBioMedicine 63:103182 PubMed33422990

2021

SARS-CoV-2 leads to a small vessel endotheliitis in the heart.

Applications

Unspecified application

Species

Unspecified reactive species

Umberto Maccio,Annelies S Zinkernagel,Srikanth Mairpady Shambat,Xiankun Zeng,Gieri Cathomas,Frank Ruschitzka,Reto A Schuepbach,Holger Moch,Zsuzsanna Varga

Nature communications 11:5453 PubMed33116139

2020

ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs.

Applications

Unspecified application

Species

Unspecified reactive species

Ivan T Lee,Tsuguhisa Nakayama,Chien-Ting Wu,Yury Goltsev,Sizun Jiang,Phillip A Gall,Chun-Kang Liao,Liang-Chun Shih,Christian M Schürch,David R McIlwain,Pauline Chu,Nicole A Borchard,David Zarabanda,Sachi S Dholakia,Angela Yang,Dayoung Kim,Han Chen,Tomoharu Kanie,Chia-Der Lin,Ming-Hsui Tsai,Katie M Phillips,Raymond Kim,Jonathan B Overdevest,Matthew A Tyler,Carol H Yan,Chih-Feng Lin,Yi-Tsen Lin,Da-Tian Bau,Gregory J Tsay,Zara M Patel,Yung-An Tsou,Alexandar Tzankov,Matthias S Matter,Chih-Jaan Tai,Te-Huei Yeh,Peter H Hwang,Garry P Nolan,Jayakar V Nayak,Peter K Jackson

bioRxiv : the preprint server for biology : PubMed32995783

2020

Common genetic variation in humans impacts susceptibility to SARS-CoV-2 infection.

Applications

Unspecified application

Species

Unspecified reactive species

Kristina Dobrindt,Daisy A Hoagland,Carina Seah,Bibi Kassim,Callan P O'Shea,Marina Iskhakova,Michael B Fernando,P J Michael Deans,Samuel K Powell,Ben Javidfar,Aleta Murphy,Cyril Peter,Rasmus Møeller,Meilin Fernandez Garcia,Masaki Kimura,Kentaro Iwasawa,John Crary,Darrell N Kotton,Takanori Takebe,Laura M Huckins,Benjamin R tenOever,Schahram Akbarian,Kristen J Brennand

medRxiv : the preprint server for health sciences : PubMed32511516

2020

Robust ACE2 protein expression localizes to the motile cilia of the respiratory tract epithelia and is not increased by ACE inhibitors or angiotensin receptor blockers.

Applications

Unspecified application

Species

Unspecified reactive species

Ivan T Lee,Tsuguhisa Nakayama,Chien-Ting Wu,Yury Goltsev,Sizun Jiang,Phillip A Gall,Chun-Kang Liao,Liang-Chun Shih,Christian M Schürch,David R McIlwain,Pauline Chu,Nicole A Borchard,David Zarabanda,Sachi S Dholakia,Angela Yang,Dayoung Kim,Tomoharu Kanie,Chia-Der Lin,Ming-Hsui Tsai,Katie M Phillips,Raymond Kim,Jonathan B Overdevest,Matthew A Tyler,Carol H Yan,Chih-Feng Lin,Yi-Tsen Lin,Da-Tian Bau,Gregory J Tsay,Zara M Patel,Yung-An Tsou,Chih-Jaan Tai,Te-Huei Yeh,Peter H Hwang,Garry P Nolan,Jayakar V Nayak,Peter K Jackson
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com